Предикторы эффективности и безопасности эндоваскулярной хирургии острого коронарного синдрома
Диссертация
Первая успешная коронарная ангиопластика была выполнена швейцарским врачом Адреасом Грюнцигом в 1977 году. За последующие тридцать лет техника ЭВ претерпела ряд усовершенствований, направленных на повышение эффективности и безопасности проводимых вмешательств — в первую очередь, снижение частоты развития рестеноза и интраоперационных осложнений. Процент неблагоприятных исходов при ЭВ относительно… Читать ещё >
Список литературы
- Рекомендации Всероссийского научного общества кардиологов по лечению ОКС без подъема сегмента ST, 2007 // Кардиоваскулярная терапия и профилактика. 2006. — Том 8. — N. 5, приложение 1.
- Рекомендации Всероссийского научного общества кардиологов по лечению ОКС с подъемом сегмента ST, 2007. // Кардиоваскулярная терапия и профилактика. 2007. — Том 6. — N. 8, приложение 1.
- Мазур Н. / «Ишемическая болезнь сердца, хроническая застойная сердечная недостаточность и внезапная сердечная смерть» // Врач. 2004. -N1.-C. 10−12.
- Недошивин А.О., Петрова Н. Н., Кутузова А. Э., Перепеч Н. Б. / Качество жизни больных с хронической сердечной недостаточностью. Эффект лечения милдронатом // Терапевтический архив. 1999. — N8. — С. 1012.
- Новик А.А., Ионова Т. Н. / Руководство по исследованию качества жизни в медицине. Издание 2-е. // Издательство «ОЛМА-медиагрупп», Москва.-2007.-С. 18−19.
- АСС/АНА Guidelines for Percutaneous Coronary Intervention, 2001 //Circulation.-2001.-N. 103.-P. 3019−3041.
- Bauters C. et al. / Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients // European Heart Journal. 2007. — Vol.28. — N 5. — P. 546−552.
- Bhatt D.L., Topol E.J. / Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? // Circulation. -2005.-N. 112.-P. 906−915.
- Bigger J.T. / Identification of patients at high risk for sudden cardiac death // Am. J. Cardiol. 1984. — N. 54 — P. 3D-8D.
- Blackman D.J., et al. / Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. // Am. Heart J. 2006. — Vol. 151.- Nl.-P. 146−152.
- Blankenberg S., Yusuf S. / Response to Letter Regarding Article, «The Inflammatory Hypothesis: Any Progress in Risk Stratification and Therapeutic Targets?» // Circulation. May 22, 2007. — N. 115 — e476.
- Blankenship J.C., Haldis T., Feit F., et al. / Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy) // Am. J. Cardiol. 2006. -N. 97.-P. 1591−1596.
- Boden W.E., et al. / Optimal Medical Therapy with or without PCI for Stable Coronary Disease //N. Engl. J. Med. 2007. -N. 356. -P. 1503−1516.
- Briel M., Schwartz G.G., Thompson P.L., et al. / Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials // JAMA 2006. — Vol. 295. -N.17. — P. 2046−2056.
- Brink E., Karlson B.W., Hallberg L.R.-M. / Health experiences of first-time myocardial infarction: factors influencing womens and mens health-related quality of life after five months // Psychol. Health. Med. 2002. — Vol. 17, № 1.- P. 5−16.
- Brodie B.R. et al. / Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction // Am. J. Cardiol. 2005. — N. 95. — P. 343−8.
- De Geare V.S., Boura J.A., Grines L.L., et al. / Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction // Am. J. Cardiol. 2001. — N. 87. — P. 1035−1038.
- De Winter R.J., Windhausen F., Cornel J.H. et al. / Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes // N. Engl. J. Med. 2005. — N. 353. — P. 1095−104.
- Daniels L.B., Clopton P., Peacock W. F., et al. / Characteristics of Aspirin Non-Responders: Results from the Aspirin Resistance Testing and Initial Strategy for Treatment (ARTIST) Multicenter Trial // Circulation. 2007. — N. 116.-P. II481.
- Dempster M., Donelly M.A. / Comparative Analysis of the SF-12 and the SF-36 among Ischemia Heart Disease Patients // J. Health Psychol. 2002. -Vol. 6.-N. 6.-P. 707−711.
- Duffy B.K., et al. / Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention // Am. J. Cardiol. 2006. — N. 97. — P. 993−996.
- Dussaillant G.R., Mint G.S., Pichard A. D,. et al. / Small stent size and intimal hyperplasia contribute to restenosis a volumetric intravascular ultrasound analysis // J. Am. Coll. Cardiol. 1995. — N. 26. — P. 720−724.
- European Society of Cardiology. Guidelines for Percutaneous Coronary Interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology, 2005 // Eur. Heart J. 2005. — N. 26. — P. 804 847.
- European Guidelines on cardiovascular disease prevention in clinical practice. 4th Joint European Societies' Task Force on Cardiovascular Disease Prevention in Clinical Practice // Eur. J. Cardio. Vase. Prev. Rehabil. 2007. — N. 4.
- European Society of Cardiology. Joint ESC/EACTS Guidelines on myocardial revascularization, 2010.
- Eikelboom J.W., Mehta S.R., Anand S.S., et al. / Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes // Circulation. 2006. — N. 114. — P. 774−782.
- Eichhorn E., et al. / A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure. The Beta-Blocker Evaluation of Survival Trial Investigators //N. Engl. J. Med. 2001. — Vol. 344. — N. 22. — P. 1659−1667.
- Ellis S.G., Savage M., Fischman D., et al. / Restenosis after placement of Palmaz-Schatz stents in native coronary arteries initial results of a multicenter experience // Circulation. 1992. -N. 86. — P. 1836−1844.
- Erbel R., Haude M., Hopp H.W., et al. / Coronary-artery stenting compared with balloon angioplasty loi restenosis after initial balloonangioplasty Restenosis Stent Study Group // N. Engl. J. Med. 1998. — N. 339. — P. 16 721 678.
- Fischman D.L., Leon M.B., Bairn D.S., et al. / A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators // N. Engl. J. Med. -1994.-N. 331.-P. 496−501.
- FRISC II: Invasive compared with non-invasive in unstable coronary-artery disease: FRISC II prospective randomized multicentre study. Lancet 1999−354:708−15.
- Gianetti J., et al. / Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study // Thromb. Res. 2006. — N. 118. — P. 487−493.
- Gibson C. M., Pride Y.B., Hochberg C.P., et al., for the TIMI Study Group / Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients
- Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome // J. Am. Coll. Cardiol. 2009. — N. 54. — P. 2290−2295.
- Glazier J.J., Varncchione T.R., Ryan T.J., et al. / Factors predicting recurrent restenosis after percutaneous transluminal coronary balloon angioplasty // Am. J. Cardiol. 1989. — N. 63. — P. 902−905.
- Gurm H.S., et al. / Preprocedural white blood cell count and death after percutaneous coronary intervention // Am. Heart. J. 2003. — N. 146. — P. 692 698.
- Halkin A., et al. / Prediction of Mortality after Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: The CADILLAC Risk Score // J. Am. Coll. Cardiol. 2005. — N. 45. — P. 1397- 1405.
- He B., et al. / Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention // Zhonghua Xin Xue Guan Bing Za Zhi. 2006. — N.34.-P. 349−352.
- Henderson R.A., Pipihs A., Cooke R., et al. / Angiographic morphology of recurrent stenoses after percutaneous transluminal coronary angioplasty are lesions longer at restenosis? // Int. J. Card. Imaging. 1990. — N. 6. — P. 77−84.
- Hochholzer W., et al. / Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement // J. Am. Coll. Cardiol. 2006. — N. 48. — P. 17 421 750.
- Hochman J.S., Lamas G.A., Buller C.E., et al. / Coronary Intervention for Persistent Occlusion after Myocardial Infarction // N. Engl. J. Med. 2006. -Vol. 355. N. 23. — P. 2395−2407.
- Holt G.W., Sugrue D.D., Bresnahan J.F., et al. / Results of percutaneous transluminal coronary angioplasty for unstable angina pectoris in patients 70 years of age and older // Am. J. Cardiol. 1988. — N. 61. — P. 994−997.
- Kappetein A.P. On behalf of the SYNTAX investigators / Optimal revascularization strategy in patients with three-vessel disease and/or left main disease // 12 September 2010, 24 EACTS Annual Meeting, Geneva, Switzerland, 1115 September 2010.
- Keeley E.C., Boura J.A., Grines C.L. / Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials // Lancet. 2003. -N. 361. — P. 13−20.
- Kereiakes D.J., Midei M., Hermiller J., et al. / Procedural and lateoutcomes following MULTI LINK DUET coronary stent deployment // Am. J. Cardiol. 1999. -N. 84. — P. 1385−1390.
- Kernis S.J., et al. / Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? // J. Am. Coll. Cardiol. -2004. -N. 43. P. 1773−1779.
- Kini A.S., Lee P., Marmur J.D., et al. / Correlation of postpercutane-ous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality // Am. J. Cardiol. 2004. — N. 93. — P. 18−23.
- Kitazume H., Ichiro K., Iwama T., et al. / Repeat coronary angioplasty as the treatment of choice for restenosis // Am. Heart J. 1996. — N. 132. — P. 711 715.
- Kizer J.R., Muttrej M.R., Matthai W.H., et al. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention / Eur. Heart J. 2003. -N. 24. — P. 1314−1322.
- Klein W., Buchwald A., Hillis W.S., et al. / Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease // Am. J. Cardiol. 1997. — Vol. 80. -N. 5A. — P. 30E-34E.
- Krasopoulos G., Brister S.J., Beattie W.S. et al. / Aspirin «resistance» and risk of cardiovascular morbidity: systematic review and meta-analysis // BMJ. -2008.-N. 336.-P. 195−198.
- Kurian A.K., Cardarelli K.M. / Racial and ethnic differences in cardiovascular disease risk factors: a systematic review // Ethn. Dis. 2007. — Vol. 17.-N. l.-P. 143−152.
- Lee P.C. / Anemia is an independent predictor of mortality after percutaneous coronary intervention // J. Am. Coll. Cardiol. 2004. -N. 44. — P. 541 546.
- Lindsay J., et al. / Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine // Catheter Cardiovasc. Interv. 2003. — N. 59. -P. 338−343.
- Liu J., et al. / Echocardiographic predictors of remote outcome in patients with angiographically successful reflow after acute myocardial infarction // Circulation.-2004.-N. 68.-P. 1004−1010.
- Lown B., Wolf M. / Approaches to sudden death from coronary heart disease//Circulation 1971. -N. 44. — P. 130−142.
- Mahanonda N., et al. / Homocysteine and restenosis after percutaneous coronary intervention // J. Med. Assoc. Thai. 2001. — Vol. 84. — Suppl. 3. -P. 636−644.
- Marcucci R., et al. / Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events // Am. J. Cardiol. 2006. -N. 98. — P. 1156−1159.
- McKechnie R.S., et al. / Prognostic Implication of Anemia on InHospital Outcomes After Percutaneous Coronary Intervention // Circulation. -2004.-N. 110.-P. 271−277.
- Mueller C., Buerkle G., Perruchoud A.P., et al. / Female sex and risk of contrast nephropathy after percutaneous coronary intervention // Can. J. Cardiol. 2004. — N. 20. — P. 505−509.
- Naidu S.S., et al. / Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention / Am. J. Cardiol. 2003. — N. 92.-P. 1160−1164.
- Narins C.R., Ling F.S., Fischi M., et al. In-hospital mortality among women undergoing contemporary elective percutaneous coronary intervention: a reexamination of the gender gap. Clin. Cardiol. — 2006. — N. 29. — P. 254−258.
- Prasad A., Stone G., Stuckey T., et al. / Relationship Between Leucocyte Count, Myonecrosis, Myocardial Perfusion and Outcomes Following Primary Angioplasty // Circulation. 2006. — N. 114. — P. 11−347.
- Prasad A., et al. / Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial // Am. Heart J. 2004. — N. 147. — P. 669−675.
- Qayyum R., Khalid R., Adomaityte J. et al. / Systematic Review: Comparing Routine and Selective Invasive Strategies for the Acute Coronary Syndrome // Ann. Intern. Med. 2008. -N. 148. — P. 186−196.
- Resnic F.S., et al. / No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention // Am. Heart J. -2003.-N. 145.-P. 42−46.
- Saleh N., et al. / Response of serum C-reactive protein to percutaneous coronary intervention has prognostic value // Clin. Chem. 2005. — N. 51. — P. 2124−2130.
- Saw J., Jokhi P., Starovoytov A., et al. / Effect Of Aspirin And Clopidogrel Resistance On Myonecrosis Following Percutaneous Coronary Intervention // Circulation. 2007. -N. 116. — P. II517-II518.
- Schnyder G. et al. / Plasma homocysteine levels and late outcome after coronary angioplasty // J. Am. Coll. Cardiol. 2002. — N. 40. — P. 1769−1776.
- Shoukat S., Gowani S.A., Jafferani A., et al. / Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention // Cardiology Research and Practice. 2010. — Vol. 2010. — Article ID 649 164.
- Simpfendorfer C., Raymond R., Schraider J., et al. / Early- and long-term results of percutaneous transluminal coronary angioplasty in patients 70 yearsof age and older with angina pectoris // Am. J. Cardiol. 1988. — N. 62. — P. 959 961.
- Singh M., Rihal C.S., Lennon R.J., et al. / Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores. // Mayo Clin. Proc. 2007. — Vol. 82. — N. 6. — P. 701−708.
- Singh M., et al. / Clinical and Angiographic Predictors of Restenosis After Percutaneous Coronary Intervention // Circulation. 2004. — N. 109. — P. 2727−2731.
- Spertus J.A., Salisbury A.C., Jones P.G., et al. / Predictors of Quality-of-Life Benefit After Percutaneous Coronary Intervention // Circulation. 2004. -N. 110.-P. 3789−3794.
- Stathopoulos I., Jimenez M., Panagopoulos G., et al. / The Decline in PCI Complication Rate: 2003−2006 Versus 1999−2002 // Hellenic J. Cardiol. -2009.-N. 50.-P. 379−387.
- Strauss W.E., Fortin T., Hartigan P. / A Comparison of Quality of Life Scores in Patients With Angina Pectoris After Angioplasty Compared With After Medical Therapy//Circulation. 1995. -N. 92. — P. 1710−1719.
- Taddci C.F.G., Weimtraub W.S., Douglas J.S. Jr, et al. / Influence ofage on outcome after percutaneous transluminal coronary angioplasty // Am. J. Cardiol. 1999. -N. 84. — P. 245−251.
- Teirstein P. S., Hoover C.A., Ligon R.W., et al. / Repeat coronary angioplasty efficacy of a third angioplasty for a second restenosis // J. Am. Coll. Cardiol. 1989. -N. 13. -P. 291−296.
- Timmer J.R., et al. / Hyperglycemia Is an Important Predictor of Impaired Coronary Flow Before Reperfusion Therapy in ST-Segment Elevation Myocardial Infarction // J. Am. Coll. Cardiol. 2005. — N. 45. — P. 999−1002.
- Thompson R.C., Holmes D.R. Jr, Gersh B.J., et al. / Percutaneous transluminal coronary angioplasty in the elderly early- and long-term results // J. Am. Coll. Cardiol. 1991. -N. 17. -P. 1245−1250.
- Thygesen K., Alpert J.S., White H.D., on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction / Universal Definition of Myocardial Infarction // Circulation. 2007. — N. 116. — P. 2634−2653.
- Tsai T.P., Chaux A., Kass R.M., et al. / Aortocoronary bypass surgery in septuagenarians and octogenarians // J. Cardiovasc. Surg. (Torino). 1989. — N. 30.-P. 364−368.
- Vismara L.A., Amsterdam B.A., Mason D.T. / Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death after hospital discharge // Am. J. Med. 1975. — N. 5. — P. 612.
- Win H.K., Caldera A.E., Maresh K, et al. / Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents // JAMA. 2007. -Vol. 297. -N. 18. — P. 2001−2009.
- World Health Organization. Cancer pain relief. Geneva: WHO, 1986.-P. 5−26.
- World Health Organization, Global burden of diseases 2004, update 2008.
- World Health Organization Regional Office for Europe (2002). Доклад о состоянии здравоохранения в Европе, 2002 г. Копенгаген, Европейское региональное бюро ВОЗ (http://www.euro.who.int/document/e76907r.pdf. По состоянию на 10 ноября 2005 г.).
- Yip НК et al., Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Chest 2005- 127:803−8.